If your email program has trouble displaying this email, view as a webpage.

TOPIC: Better Weather Fix Elixir Products by XD Investments: Recall - Due to Undeclared Mitragynine and Mitragynine Pseuoindoxyl

AUDIENCE: Consumer, Health Care Provider, Pharmacy, Gastroenterology, Neurology, Cardiology 

ISSUE: XD Investments is recalling approximately 448 Boxes of Better Weather Fix Elixir products, including all flavors and variations, because FDA analysis found the products to contain undeclared Mitragynine and Mitragynine Pseudoindoxyl (MP). MP is a more potent derivative of Mitragynine, or Kratom. Consumption of MP can produce undesirable effects such as nausea, vomiting, rapid heart rate (tachycardia), palpitations, hallucinations, sedation, anxiety, and loss of consciousness. It can also fatally suppress the respiratory system. Consumption of Mitragynine, especially MP, often causes addiction with severe opioid withdrawal symptoms. Consumption of products that contain Mitragynine or MP, especially in the context of concomitant use of other drugs (prescribed or illicit), could result in other severe or fatal physiological effects.

The affected products were sold online through xdeor.com and maxensupplements.com between approximately November 9, 2025 and March 28, 2026.

To date, XD Investments has not received any reports of adverse events related to the recalled products.

For more information about this recall, click on the red button "Read Recall" below.

BACKGROUND: The product being recalled is sold as dietary supplement.

RECOMMENDATIONS: 

• Consumers experiencing adverse reactions or other health concerns related to use of the product being recalled should contact a healthcare provider.

• Consumers who purchased Better Weather Fix Elixir products should immediately stop using the product. Consumers may dispose of the product or contact XD Investments for refund information and additional assistance.

• Consumers with questions regarding this recall may contact: XD Investments at info@xdeor.com.

Health care professionals, consumers and patients are encouraged to report adverse events or side effects related to the use of these products to the FDA's MedWatch Safety Information and Adverse Event Reporting Program:

• Complete and submit the report online.
• Download form or call 1-800-332-1088 to request a reporting form, then complete and return to the address on form, or submit by fax to 1-800-FDA-0178.

Follow us on X at @FDAMedWatch